A recent online article dated June 4, 2015 regarding a planned clinical trial peaked my interest. It seems the way has been cleared for the beginning phase for a clinical trial of a Q-Cell product in patients with ALS. Q-Cells are glial-restricted progenitor cells or GRPs, which are early descendants of neural stem cells that produce only glia. Glia make up 50% of cells found in the brain and are essential for supporting, maintaining, and even restoring neuron health. Animal models of ALS and other central nervous (CNS) diseases have demonstrated that delivery of healthy glial cells into the brain and spinal cord has the potential to modify the course of currently incurable CNS diseases (such as ALS) and CNS injuries.
Someone in the world is diagnosed wit ALS every 90 minutes, and current therapies are not much better than when my husband was diagnosed in 2003. it seems more promising to me than other clinical trials because it, if I am reading correctly, involves some derivative of stem cells. Since that time there have been thousands of people diagnosed with this horrendous disease. I hope and pray that this will prove at least to be a beginning milestone in the quest for better treatment, or "Please God" even a cure.
For more information visit www.qthera.com
No comments:
Post a Comment